To ask the Scottish Government what action it is taking to raise awareness, among people diagnosed with or at risk from cervical cancer, regarding the availability of the drug pembrolizumab on the NHS. In Scotland, the Scottish Medicines Consortium (SMC) appraises the clinical and cost-effectiveness of newly-licensed medicines.